FY2027 Earnings Forecast for ISRG Issued By Erste Group Bank

Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) – Investment analysts at Erste Group Bank dropped their FY2027 EPS estimates for shares of Intuitive Surgical in a research note issued to investors on Wednesday, July 15th. Erste Group Bank analyst H. Engel now expects that the medical equipment provider will earn $9.91 per share for the year, down from their previous estimate of $9.94. The consensus estimate for Intuitive Surgical’s current full-year earnings is $8.62 per share.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.45% and a return on equity of 17.09%. The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the business earned $1.81 EPS. The firm’s revenue was up 23.0% compared to the same quarter last year.

Several other analysts also recently commented on ISRG. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating on the stock in a research report on Tuesday, June 2nd. Citigroup dropped their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday. Sanford C. Bernstein cut their price target on Intuitive Surgical from $750.00 to $685.00 and set an “outperform” rating for the company in a research note on Friday. Leerink Partners decreased their price target on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday. Finally, Jefferies Financial Group lowered their price objective on Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating on the stock in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, twenty have issued a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $523.46.

View Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Price Performance

ISRG opened at $345.42 on Monday. The company has a 50 day simple moving average of $415.28 and a two-hundred day simple moving average of $467.12. The firm has a market cap of $122.33 billion, a P/E ratio of 39.57, a PEG ratio of 2.80 and a beta of 1.46. Intuitive Surgical has a 1-year low of $344.55 and a 1-year high of $603.88.

Insider Activity

In related news, Director Amy L. Ladd sold 119 shares of the firm’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the completion of the sale, the director directly owned 120 shares in the company, valued at $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the transaction, the executive vice president directly owned 5,720 shares of the company’s stock, valued at $2,426,080.80. The trade was a 6.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,169 shares of company stock valued at $3,059,135 in the last ninety days. Insiders own 0.60% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in ISRG. Newbridge Financial Services Group Inc. boosted its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 33 shares during the period. Olistico Wealth LLC purchased a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Main Street Group LTD purchased a new stake in Intuitive Surgical in the 1st quarter worth about $30,000. Laurel Wealth Advisors LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $31,000. Finally, Vermillion Wealth Management Inc. lifted its stake in shares of Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after acquiring an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

  • Positive Sentiment: Intuitive Surgical reported stronger-than-expected Q2 revenue and earnings, helped by solid demand for its da Vinci robotic surgery systems and continued adoption of its products. Reuters article
  • Positive Sentiment: The company still reported healthy procedure growth overall, with worldwide procedures rising and placements of robotic systems remaining strong, which supports the long-term investment case. Yahoo Finance article
  • Neutral Sentiment: Several analysts lowered price targets after the report, but most kept bullish ratings such as overweight, buy, or outperform, suggesting Wall Street still sees meaningful upside despite the near-term pullback. Benzinga article
  • Negative Sentiment: Management did not raise its forecast for procedure growth, and investors reacted badly to slower U.S. procedure growth and a cautious full-year outlook. Benzinga article
  • Negative Sentiment: Reuters also noted concerns that changes to some insurance plans could reduce demand, adding to worries about slower U.S. growth and a softer near-term procedure trajectory. Reuters article

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Further Reading

Earnings History and Estimates for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.